SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chih-Che Lin, Catherine Kabiling, Chao-Long Chen, Yu-Hung Lin, Yueh-Wei Liu, Chih-Chi Wang, Tsung-Hui Hu, King-Wah Chiu, Section 13. Short-Course Pretransplant Antiviral Therapy is a Feasible and Effective Strategy to Prevent Hepatitis C Recurrence After Liver Transplantation in Genotype 2 Patients, Transplantation, 2014, 97, S47

    CrossRef

  2. 2
    Sung Won Lee, Si Hyun Bae, Management of Hepatitis C Viral Infection Pre- and Post-liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 1, 1

    CrossRef

  3. 3
    Cyril Féray, Liver transplantation as a model to better understand the cell entry of hepatitis C virus, Journal of Hepatology, 2011, 54, 4, 825

    CrossRef

  4. 4
    Jan Peveling-Oberhag, Stefan Zeuzem, Wolf Peter Hofmann, Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation, Medical Microbiology and Immunology, 2010, 199, 1, 1

    CrossRef

  5. 5
    Yasuhiko Sugawara, Sumihito Tamura, Norihiro Kokudo, Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  6. 6
    François Bailly, Si Nafa Si Ahmed, Pierre Pradat, Christian Trepo, Management of nonresponsive hepatitis C, Expert Review of Anti-infective Therapy, 2010, 8, 4, 379

    CrossRef

  7. 7
    Jose A. Carrión, Eva Martínez-Bauer, Gonzalo Crespo, Santseharay Ramírez, Sofia Pérez-del-Pulgar, Juan Carlos García-Valdecasas, Miquel Navasa, Xavier Forns, Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study, Journal of Hepatology, 2009, 50, 4, 719

    CrossRef

  8. 8
    A. IACOBELLIS, M. SICILIANO, B. E. ANNICCHIARICO, M. R. VALVANO, G. A. NIRO, L. ACCADIA, N. CARUSO, G. BOMBARDIERI, A. ANDRIULLI, Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients, Alimentary Pharmacology & Therapeutics, 2009, 30, 2
  9. 9
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  10. 10
    L. Margusino Framiñán, F. Suárez López, I. Martín Herranz, Profilaxis y tratamiento de la hepatopatía por virus C en el entorno del trasplante hepático. Revisión narrativa, Farmacia Hospitalaria, 2008, 32, 2, 102

    CrossRef

  11. 11
    Luis Margusino Framiñán, Francisco Suárez López, Isabel Martín Herranz, The Profilaxis and Treatment of C Virus Liver Disease in the Liver Transplantation Setting. Narrative Review, Farmacia Hospitalaria (English Edition), 2008, 32, 2, 102

    CrossRef

  12. 12
    Felice Piccinino, Nicola Coppola, Antiviral treatment of HCV-related cirrhosis, Digestive and Liver Disease, 2007, 39, S96

    CrossRef

  13. 13
    Paul Y. Kwo, Romil Saxena, Oscar W. Cummings, A. Joseph Tector, Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus, Liver Transplantation, 2007, 13, 12
  14. 14
    Marina Berenguer, Viral hepatitis after liver transplantation, Hepatology Research, 2007, 37,
  15. 15
    Jules L. Dienstag, John G. McHutchison, American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006, 130, 1, 231

    CrossRef

  16. 16
    Bruno Roche, Didier Samuel, Aspects of hepatitis C virus infection relating to liver transplantation, European Journal of Gastroenterology & Hepatology, 2006, 18, 4, 313

    CrossRef

  17. 17
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  18. 18
    Scott W. Biggins, Norah A. Terrault, Management of Recurrent Hepatitis C in Liver Transplant Recipients, Infectious Disease Clinics of North America, 2006, 20, 1, 155

    CrossRef

  19. 19
    Marina Berenguer, Manejo de la infección por el virus de la hepatitis C en el trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 7, 422

    CrossRef

  20. 20
    A. Feliu, J. A. Carrión, A. Massaguer, E. Martínez-Bauer, M. García-Retortillo, P. González, J. Costa, J. M. Sánchez-Tapias, X. Forns, Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2006, 13, 8
  21. 21
    Paul H. Hayashi, Adrian M. Di Bisceglie, The Progression of Hepatitis B– and C–Infections to Chronic Liver Disease and Hepatocellular Carcinoma: Presentation, Diagnosis, Screening, Prevention, and Treatment of Hepatocellular Carcinoma, Infectious Disease Clinics of North America, 2006, 20, 1, 1

    CrossRef

  22. 22
    Jean-Michel Pawlotsky, Therapy of hepatitis C: From empiricism to eradication, Hepatology, 2006, 43, S1
  23. 23
    Karen F. Murray, Robert L. Carithers, AASLD practice guidelines: Evaluation of the patient for liver transplantation, Hepatology, 2005, 41, 6
  24. 24
    Gregory T. Everson, Antiviral therapy in the liver transplant candidate and recipient, Current Hepatitis Reports, 2005, 4, 2, 75

    CrossRef

  25. 25
    Lluís Castells, Víctor Vargas, Helena Allende, Itxarone Bilbao, José Luis Lázaro, Carlos Margarit, Rafael Esteban, Jaime Guardia, Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation, Journal of Hepatology, 2005, 43, 1, 53

    CrossRef

  26. 26
    J.M. Moreno Planas, E. Rubio González, E. Boullosa Graña, M. Fernández Ruiz, M. Jiménez Garrido, J.L. Lucena de la Poza, F. Martı́nez Arrieta, C. Molina Miliani, V. Sánchez Turrión, V. Cuervas-Mons Martı́nez, Effectiveness of Pegylated Interferon and Ribavirin in Patients With Liver HCV Cirrhosis, Transplantation Proceedings, 2005, 37, 3, 1482

    CrossRef

  27. 27
    Marina Berenguer, Hepatitis C after liver transplantation: risk factors, outcomes, and treatment, Current Opinion in Organ Transplantation, 2005, 10, 2, 81

    CrossRef

  28. 28
    Robert S. Brown, Hepatitis C and liver transplantation, Nature, 2005, 436, 7053, 973

    CrossRef

  29. 29
    Gregory T. Everson, Management of cirrhosis due to chronic hepatitis C, Journal of Hepatology, 2005, 42, 1, S65

    CrossRef

  30. 30
    Hector Rodriguez-Luna, Hugo E. Vargas, Management of hepatitis C virus infection in the setting of liver transplantation, Liver Transplantation, 2005, 11, 5
  31. 31
    Jos?? R. Foruny, Javier Bl??zquez, Ana Moreno, Rafael B??rcena, Luis Gil-Grande, Carmen Quereda, Mar??a J. P??rez-El??as, Javier Moreno, Juan S??nchez, Alfonso Muriel, Miguel A. Rodriguez-Sagrado, Santiago Moreno, Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization, European Journal of Gastroenterology & Hepatology, 2005, 17, 11, 1157

    CrossRef

  32. 32
    Gregory T. Everson, Should we treat patients with chronic hepatitis C on the waiting list?, Journal of Hepatology, 2005, 42, 4, 456

    CrossRef

  33. 33
    Paul H. Hayashi, Adrian M. Di Bisceglie, The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma, Medical Clinics of North America, 2005, 89, 2, 345

    CrossRef

  34. 34
    Gregory T. Everson, James Trotter, Lisa Forman, Marcelo Kugelmas, Arthur Halprin, Barbara Fey, Catherine Ray, Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy, Hepatology, 2005, 42, 2
  35. 35
    Marina Berenguer, Treatment of Hepatitis C after Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 579

    CrossRef

  36. 36
    Gregory T. Everson, Treatment of Hepatitis C in Patients Who Have Decompensated Cirrhosis, Clinics in Liver Disease, 2005, 9, 3, 473

    CrossRef

  37. 37
    Scott W. Biggins, Norah A. Terrault, Treatment of Recurrent Hepatitis C After Liver Transplantation, Clinics in Liver Disease, 2005, 9, 3, 505

    CrossRef

  38. 38
    Doris B. Strader, Teresa Wright, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4
  39. 39
    Hector Rodriguez-Luna, David D Douglas, Natural history of hepatitis C following liver transplantation, Current Opinion in Infectious Diseases, 2004, 17, 4, 363

    CrossRef

  40. 40
    MATTHIAS J BAHR, MICHAEL P MANNS, Treatment of chronic HCV infection in compensated and decompensated cirrhosis, Journal of Gastroenterology and Hepatology, 2004, 19,
  41. 41
    Xavier Forns, Miquel Navasa, Juan Rodés, Treatment of HCV infection in patients with advanced cirrhosis, Hepatology, 2004, 40, 2
  42. 42
    Alastair D Smith, Don C Rockey, Viral hepatitis C, The Lancet, 2004, 363, 9409, 661

    CrossRef